# CSPC Innovation Pharma

CSPC Pharmaceutical Group 的子公司，为全球药物供给生产咖啡因、可可碱和其他甲基黄嘌呤 API，并持有支持向监管市场出口的 DMF 注册。

Source: https://cn.bioecon.ru/companies/cspc-innovation-pharma/
Updated: 2026-07-27

- 国家: China
- 代码: HKEX:1093

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 成立 | 1991 | https://en.xnwpharma.net/about/index.html |
| 员工人数 | 员工2,369人 | https://www.marketscreener.com/quote/stock/CSPC-INNOVATION-PHARMACEU-103585616/company/ |
| 营收 | 3,240,242,226.11元人民币 | https://doc.irasia.com/listco/hk/cspc/announcement/a260817.pdf |
| 营收 | 3,240,242,226.11元人民币 (2026-06-30) | https://doc.irasia.com/listco/hk/cspc/announcement/a260817.pdf |
| 认证 | GMP、ISO 体系、BRC、KOSHER | https://en.xnwpharma.net/about/index.html |
| 认证 | CEP（欧洲药典适用性证书） | https://apibureau.com/company/15163 |
| 监管批准 | US-DMF、欧盟GMP、日本PMDA | https://chemxpert.com/download-summary-companygroup?searchType=1&value=Cspc+Nbp+Pharmaceutical+Co+Group |
| 监管批准 | CDE, DMF, CEP | https://apibureau.com/company/15163 |
| 生产基地 | 中国石家庄的南北两个生产园区,以及台州的一处厂区 | https://en.xnwpharma.net/about/index.html |

独立来源: apibureau.com, chemxpert.com, doc.irasia.com, en.xnwpharma.net, marketscreener.com

## 技术

- [生物合成可可碱](https://cn.bioecon.ru/technology/biosynthetic-theobromine/)